In addition to its high cytotoxicity, some tumors become resistant to this chemotherapeutic due to development of MDR, mainly characterized by overexpression of P-gp and MRP-1 [3], to which has been attributed the failure of cancer therapy in over 90% of patients. Here, PGP is linked to cancer.